JCB, Volume 23, Number 1, 2017 Commentary Vol.23 No. 1 (2017) 21st Century Pharmacovigilance: Intuition, Science, and the Role of Artificial Intelligence Peter J. Pitts In an environment of real world evidence, patient reported outcomes, expanding expedited and conditional review pathways for the treatment not only for cancers, but for a broad spectrum o Commentary Vol.23 No. 1 (2017) Agricultural Biotechnology Is Much More Than Herbicide-Tolerant Crops Henry I. Miller Herbicide-tolerant genetically engineered (GE) plants have been a lightning rod for activists, who regularly attack them, citing a number of spurious objections. Contrary to their claims, th Article Vol.23 No. 1 (2017) R&D Spending & Success: Key Trends, Issues & Solutions Sanjay Kumar Rao Debates about rising bio/pharmaceutical prices are often predicated on the presumption that higher product prices are necessary for continuing funding of innovation. Recent trends only pa Article Vol.23 No. 1 (2017) Analysis of Genetically Modified Food Induced International Trade Law Issues Jiansheng Zhang The advantages of genetically modified food are gradually highlighted because of the rapid development of modern transgenic technology. The trade proportion of genetically modified food in i Article Vol.23 No. 1 (2017) Genetic Diversity Assessment and its Importance on Crop improvement in Ethiopia: Potentials and challenges Obssi Dessalegn Hora Genetic diversity assessments of plant play a great role in a predictable area to improve agricultural production and productivity, to solve food uncertainty in developing world. Ma Article Vol.23 No. 1 (2017) A Guide to Time lag and Time lag Shortening Strategies in Oncology-Based Drug Development Berna Uygur One of the ongoing challenges for academic, biotech and pharma organizations involved in oncology-related research and development is how to help scientists be more effective in transforming Intellectual Property Management Vol.23 No. 1 (2017) Intellectual Property Challenges for the Modern Biotechnology Enterprise: An Overview Mindaugas Kiskis The paper investigates the IP protection in the field of biotechnology among new innovators. Incompatibilities of the development process in modern biotechnology and the current IP systems a Intellectual Property Management Vol.23 No. 1 (2017) Patenting Genomics Innovations: Post-Myriad Challenges and Possibilities Tuhin Chatterjee Patenting gene and its nucleotide sequence has been a controversial subject since the release of working draft of the Human Genome Project. A number of US Supreme Court judgments pronounc Intellectual Property Management Vol.23 No. 1 (2017) Successful Strategies for Diagnostic Method Patents Alan Douglas Miller This article ad